Secondary CD5+ Diffuse large B-Cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome)

American Journal of Clinical Pathology

Volumn 131, Issue 3, 2009, Pages 339-346

  Maeshima, Akiko Miyagi ^a   Taniguchi, Hirokazu ^a   Nomoto, Junko ^a   Maruyama, Dai ^a   Kim, Sung Won ^a   Watanahe, Takashi ^a   Kohayashi, Yukio ^a   Tobinai, Kemei ^a   Matsuno, Yoshihiro ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD5; Diffuse large B cell lymphoma; Immunohistochemistry; Non Richter syndrome; Secondary disease

Indexed keywords

CARBOPLATIN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE COURSE; DNA EXTRACTION; DNA SEQUENCE; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIMODALITY CANCER THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; BIOSYNTHESIS; CLASSIFICATION; LARGE CELL LYMPHOMA; METABOLISM; PATHOLOGY;

ANTIGENS, CD5; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; POLYMERASE CHAIN REACTION;

EID: 62449287543     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP58FETFGLCKKW     Document Type: Article

References (21)

1. Harris NL, Ferry JA. Follicular lymphoma. In: Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:823-853.
2. Kipps TJ. The CD5 B cell. Adv Immunol. 1989;47:117-185.
3. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207-216.
4. Kroft SH, Howard MA, Picker LJ, et al. De novo CD5+ diffuse large B-cell lymphomas: a heterogeneous group containing an unusual form of splenic lymphoma. Am J Clin Pathol. 2000;114:523-533.
5. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
6. Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007;109:478-485.
7. Ferry JA, Yang WI, Zukerberg LR, et al. CD5+ extranodal marginal zone B-cell (MALT) lymphoma: a low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol. 1996;105:31-37.
8. Ballesteros E, Osbome BM, Matsushima AY. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol 1998;22:201-207.
9. Lin CW, O'Brien S, Faber J, et al. De novo CD5+ Burkitt lymphoma/leukemia. Am J Clin Pathol. 1999;112:828-835.
10. Tiesinga JJ, Wu CD, Inghirami G. CD5+ follicle center lymphoma: immunophenotyping detects a unique subset of "floral" follicular lymphoma. Am J Clin Pathol. 2000;114:912-921.
11. Barekman CL, Aguilera NA, Abbondanzo SL. Low-grade B-cell lymphoma with coexpression of both CD5 and CD10: a report of 3 cases. Arch Pathol Lab Med. 2001;125:951-953.
12. Barry TS, Jaffe ES, Kingma DW, et al. CD5+ follicular lymphoma: a clinicopathologic study of three cases. Am J Clin Pathol. 2002;118:1051-1057.
13. Catherwood MA, Venkatraman L. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas [letter]. Am J Clin Pathol. 2006;125:954-955.
14. Vasallo J, Bousquet M, Quelen C, et al. CD5-positive diffuse large B-cell lymphoma arising from a CD5-positive follicular lymphoma. J Clin Pathol. 2007;60:573-575.
15. Miyawaki S, Machii T, Hirabayashi H, et al. Splenic lymphoma with callous lymphocytes with CD5+, CD1 lc+ B-cell phenotype. Intern Med. 1993;32:472-475.
16. Fujisawa S, Tanioka F, Matsuoka T, et al. CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma, Int Hematol. 2005;81:315-318.
17. Maeshima AM, Omatsu M, Nomoto J, et al. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical and FISH analyses. Cancer Sci. 2008;99:1760-1768.
18. Hans SP, Weisenburger DD, Greiner TC, et al. Conformation of molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
19. Sekiguchi N, Kobayashi Y, Yokota Y, et al. Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer Sci. 2005;96:77-82.
20. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50:696-702.
21. H mutational status and clonality analysis of Richter's transformation. Am J Surg Pathol. 2007;31:1605-1614.